Effect of COVID-19 on Platelet Aggregation

Clinical Trial ID NCT04447131

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04447131

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 82.86
2 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020 10.16
3 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 6.59
4 Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010 1.41
5 Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets 2008 1.16
6 In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest 2012 0.98
7 Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb Res 2012 0.87
8 Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med 2015 0.82
Next 100